title: The impact of re-excision of inadequately resected soft tissue sarcomas on surgical therapy, results, and prognosis: A single institution experience with 682 patients.
abstract: OBJECTIVE
  Due to their rare incidence soft tissue sarcomas (STS) are often resected without clear margins. The aim of this study was to investigate the impact of re-excision of STS on survival.
  
  
  METHODS
  Out of 752 patients with STS (406 men and 346 women, average age 51 years), 310 patients were referred after an inadequate resection, 442 patients presented for primary treatment. Six hundred eighty-two patients were compared over a mean period of 65 months (median, 36 months) according to the treatment groups regarding their survival, clinical, surgical, and pathological data.
  
  
  RESULTS
  The 5-year survival rate of 621 surgically treated patients was 53.9%. There was a continuous improvement in survival during the whole treatment period in the respective decades. The overall survival rate in both groups was not significantly different regardless of low- or high-grade malignancies. Patients with a re-resection did not have a higher rate of local recurrences; patients with a primary resection had a worse prognosis regarding metastases. A re-resection within 12 weeks indicated a better prognosis.
  
  
  CONCLUSIONS
  An inadequate excision of a STS does not cogently mean deterioration of overall survival but necessitates an ample and quick re-resection.
authors.affiliation: Department of Orthopaedic Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. philipp.funovics@meduniwien.ac.at
authors.forename: Philipp T
authors.initials: PT
authors.lastname: Funovics
authors.forename: Sanja
authors.initials: S
authors.lastname: Vaselic
authors.forename: Joannis
authors.initials: J
authors.lastname: Panotopoulos
authors.forename: Rainer I
authors.initials: RI
authors.lastname: Kotz
authors.forename: Martin
authors.initials: M
authors.lastname: Dominkus
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D019233:Retreatment; D012189:Retrospective Studies; D012509:Sarcoma / Q000401:mortality / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome